2018 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2015 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2018 | 0 | 12.715.114 | 173.813 | 2 | ||
2015 | 0 | 5.087.507 | 100.375 | 1 | ||
2011 | 0 | 5.376.180 | 113.520 | 1 |
Total number of partners: 34
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 34
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2018-01-01 | A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis | OligoGpivotalCF | participant | 6.013.749 | 6 |
2018-01-01 | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | HIT-CF | participant | 6.701.365 | 10 |
2015-01-01 | Innovative approach for self-management and social welfare of Cystic Fibrosis patients in Europe: development, validation and implementation of a telematics tool. | MyCyFAPP | participant | 5.087.507 | 12 |
2011-01-01 | Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment | IMPACTT | participant | 5.376.180 | 10 |